Skip to Content

Join the 'Pancreatic Cancer' group to help and get support from people like you.

Pancreatic Cancer News

Related terms: Cancer, Pancreas, Cancer, Pancreatic, Pancreatic Carcinoma

Women's Cancer Risk Rises With Years Spent Overweight

Posted 16 Aug 2016 by Drugs.com

TUESDAY, Aug. 16, 2016 – The longer a woman is overweight, the higher her risk of several cancers, researchers report. The study, which followed nearly 74,000 U.S. women, found that the longer a woman carried excess poundage, the greater her risk of breast, endometrial, colon and kidney cancers. "We've known for a long time that excess weight is important in cancer risk," said Susan Gapstur, vice president of epidemiology for the American Cancer Society. The cancer society says excess weight contributes to as many as 20 percent of all cancer deaths. "This study is interesting because it suggests that the number of years you spend being overweight also matters," said Gapstur, who was not involved in the research. And that, she said, should provide further incentive to avoid excess weight gain in the first place. Currently, about 7 out of 10 adults in the United States are overweight, ... Read more

Related support groups: Obesity, Cancer, Breast Cancer, Weight Loss, Colorectal Cancer, Ovarian Cancer, Pancreatic Cancer, Bladder Cancer, Urinary Tract Cancer

Health Insurance Status May Affect Cancer Patients' Survival

Posted 8 Aug 2016 by Drugs.com

MONDAY, Aug. 8, 2016 – Two large studies suggest that surviving certain cancers in America could depend on your health insurance status. Despite improvements in cancer diagnosis and treatment, patients who were uninsured or had Medicaid coverage were more likely to suffer worse outcomes, compared with people who have other forms of health insurance, the studies found. People who were uninsured or relied on Medicaid were diagnosed at a later stage, received sub-optimal treatment and had shorter survival, the findings showed. In the case of testicular cancer, they were at greater risk of death from their disease than patients with other insurance, the researchers found. The findings, published online Aug. 8 in the journal Cancer, add to evidence linking poor outcomes and inadequate health insurance. Dr. Christopher Sweeney, a medical oncologist at the Dana-Farber Cancer Institute in ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Basal Cell Carcinoma, Brain Tumor, Melanoma, Skin Cancer, Pancreatic Cancer, Ovarian Cancer, Cervical Cancer, Melanoma - Metastatic

New Guidelines Issued for Cancer Patients' Post-Treatment Pain

Posted 29 Jul 2016 by Drugs.com

FRIDAY, July 29, 2016 – More people are surviving cancer, but many are left with persistent pain after treatment. New guidelines from the American Society of Clinical Oncology (ASCO) recommend that doctors routinely screen for such pain. The guidelines also advise doctors to consider the use of non-traditional treatments for pain. These include hypnosis, meditation and medical marijuana where it's legal. ASCO also cautioned doctors to assess patients' risk for overuse of opioid painkillers. "Many oncologists and primary care physicians are not trained to recognize or treat long-term pain associated with cancer," guideline panel co-chair Judith Paice said in an ASCO news release. "This guideline will help clinicians identify pain early and develop comprehensive treatment plans, using a broad range of approaches," she said. Advances in cancer diagnosis and treatment have led to a record ... Read more

Related support groups: Pain, Suboxone, Oxycodone, Hydrocodone, Methadone, Percocet, Tramadol, Cancer, OxyContin, Vicodin, Norco, Fentanyl, Morphine, Codeine, Lortab, Tylenol, Chronic Pain, Opana, Ibuprofen, Subutex

Global Recession May Have Contributed to Cancer Deaths

Posted 26 May 2016 by Drugs.com

THURSDAY, May 26, 2016 – The 2008 global economic crisis has been linked to a sharp rise in deaths from cancer, a new study reports. Unemployment and cuts in public health-care spending were associated with more than 260,000 additional cancer deaths by 2010. Most of those deaths – 160,000 – were in the European Union, the researchers said. The study included 70 countries and a total of more than 2 billion people, according to the report published online May 25 in The Lancet. "Cancer is a leading cause of death worldwide, so understanding how economic changes affect cancer survival is crucial," lead author Dr. Mahiben Maruthappu, of Imperial College London, said in a journal news release. "We found that increased unemployment was associated with increased cancer mortality, but that universal health coverage protected against these effects. This was especially the case for treatable ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Non-Small Cell Lung Cancer, Melanoma, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Endometrial Cancer, Cervical Cancer, Bladder Cancer, Melanoma - Metastatic, Stomach Cancer, Breast Cancer - Palliative, Gastric Cancer, Testicular Cancer, Solid Tumors

Too Many Advanced Cancer Patients Lack Info About Their Disease

Posted 23 May 2016 by Drugs.com

MONDAY, May 23, 2016 – Many patients battling advanced cancer lack basic information about their prognosis or treatment, meaning they can't make informed decisions about their care, a small new study suggests. "These were people with highly lethal metastatic cancers that had progressed after at least one prior line of chemotherapy; their life expectancy was approximately four months from our interview," said lead researcher Dr. Holly Prigerson. She is a professor of geriatrics at Weill Cornell Medicine in New York City. "We were astonished to learn that only 5 percent of this sample had sufficient knowledge about their illness to make informed decisions about their care," Prigerson said in a Weill Cornell news release. The findings highlight the need for doctors to improve communication with these patients, she said. In the study, Prigerson's team compared 178 advanced cancer patients' ... Read more

Related support groups: Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Endometrial Cancer, Cervical Cancer, Bladder Cancer, Melanoma - Metastatic, Stomach Cancer, Head and Neck Cancer, Breast Cancer - Palliative, Gastric Cancer, Testicular Cancer, Solid Tumors

Additional Treatments Offer Little Benefit for Pancreatic Cancer: Study

Posted 3 May 2016 by Drugs.com

TUESDAY, May 3, 2016 – Additional treatments for locally advanced pancreatic cancer don't appear to boost survival, a new French study reports. Researchers looked at the effects of adding a second drug – erlotinib (Tarceva) – to the initial round of chemotherapy. They also tested whether adding radiation to a second round of chemotherapy (chemoradiotherapy) would offer any survival benefit. Unfortunately, the addition of the second drug didn't help people live longer, and those on chemoradiotherapy didn't fare any better. "Chemoradiotherapy was not superior to chemotherapy," said the study's senior author, Dr. Pascal Hammel. Hammel is from the department of gastroenterology-pancreatology at Beaujon Hospital, in Clichy, France. The study was funded by the pharmaceutical company Roche, the maker of Tarceva, and the French National Institute of Cancer. More than 53,000 Americans are ... Read more

Related support groups: Tarceva, Pancreatic Cancer, Nausea/Vomiting - Chemotherapy Induced, Erlotinib, History - Radiation Therapy

Could Talk Therapy Ease Chemo-Related Memory Issues?

Posted 2 May 2016 by Drugs.com

MONDAY, May 2, 2016 – A type of psychotherapy might help cancer survivors deal with the long-term thinking problems some experience after chemotherapy, researchers say. It's estimated that about half of those who undergo chemotherapy for cancer develop what's often called "chemo brain." For instance, they may have trouble following conversations or remembering the steps in a project, according to background notes with the new study. Although usually mild, these changes can affect quality of life, job performance and relationships, said the researchers from the Eastern Maine Medical Center and Lafayette Family Cancer Center in Bangor, Maine. The researchers developed a cognitive-behavioral therapy (CBT) program called Memory and Attention Adaptation Training to help cancer survivors prevent or manage these memory problems. Their study involved 47 breast cancer survivors who underwent ... Read more

Related support groups: Cancer, Methotrexate, Breast Cancer, Prostate Cancer, Fluorouracil, Gleevec, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Breast Cancer, Metastatic, Brain Tumor, Non-Small Cell Lung Cancer, Melanoma, Skin Cancer, Xeloda, Tasigna, Pancreatic Cancer, Ovarian Cancer, Endometrial Cancer, Hydroxyurea

Study Ties Certain Mouth Germs to Pancreatic Cancer Risk

Posted 20 Apr 2016 by Drugs.com

WEDNESDAY, April 20, 2016 – A new study suggests a possible link between certain germs found in the mouth and a heightened risk of pancreatic cancer. "We identified two types of bacteria that are associated with a higher risk for pancreatic cancer and have been tied in the past to such diseases as periodontitis, or inflammation of the gums," explained lead researcher Jiyoung Ahn. She's an associate professor of population health at NYU Langone Medical Center, in New York City. Ahn stressed, however, that her team found only an association and "cannot tell if this bacteria causes the cancer." One strain of mouth bacteria was associated with a 59 percent higher risk for pancreatic cancer in people who carried it, while the other was linked to a 119 percent greater risk of the cancer, the researchers said. Those numbers reflect a person's risk of developing pancreatic cancer compared to ... Read more

Related support groups: Oral and Dental Conditions, Gingivitis, Pancreatic Cancer, Periodontitis, Diagnosis and Investigation, Stomatitis, Prevention of Dental Caries

'Palliative Care' Gets a Bad Rap, Study Finds

Posted 19 Apr 2016 by Drugs.com

TUESDAY, April 19, 2016 – The term "palliative care" triggers negative feelings among many cancer patients, and needs "rebranding," researchers say. The stigma surrounding palliative care can mean patients wait too long to receive supportive care that improves their quality of life, said researchers at the Princess Margaret Cancer Center in Toronto. This new study shows there's a "branding issue," said principal investigator Dr. Camilla Zimmermann, head of palliative care for the hospital and the University Health Network. Palliative care "is not something to be afraid of or that is stigmatizing, but is helpful even while patients are receiving life-prolonging therapies," Zimmermann said in a network news release. She and her colleagues analyzed interviews with 48 patients who had advanced cancer and an estimated survival of between six and 24 months. Half the patients received early ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Melanoma, Skin Cancer, Pancreatic Cancer, Ovarian Cancer, Cervical Cancer, Melanoma - Metastatic, Stomach Cancer, Head and Neck Cancer, Breast Cancer, Prevention, Breast Cancer - Palliative, Gastric Cancer, Testicular Cancer, Salivary Gland Cancer, Urinary Tract Cancer

Marriage May Be a Cancer Fighter

Posted 11 Apr 2016 by Drugs.com

MONDAY, April 11, 2016 – A wedding band may be powerful medicine against cancer, a new study suggests. Married people seem to have a marked survival advantage, the researchers found: Single men with cancer had a death rate 27 percent higher than it was for married male patients, while the death rate for single female patients was 19 percent higher than their married counterparts. "The effects that we find were actually quite notable," said study author Scarlett Lin Gomez, a research scientist with the Cancer Prevention Institute of California. "They are comparable to some of the more clinical factors we often see that are associated with cancer prognosis, like stage of disease or certain types of treatment." What's more, this advantage appears to rely solely on the emotional bonds of matrimony, and not the financial advantages that marriage offers, Gomez said. "These patterns were very ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Skin Cancer, Pancreatic Cancer, Ovarian Cancer, Cervical Cancer, Stomach Cancer, Head and Neck Cancer, Gastric Cancer, Testicular Cancer, Urinary Tract Cancer

Is Type 1 Diabetes Linked to Raised Risk of Certain Cancers?

Posted 2 Mar 2016 by Drugs.com

TUESDAY, March 1, 2016 – Having type 1 diabetes may raise the risk of some cancers, but lower the risk of others, a new study suggests. A higher risk was seen for cancers of the stomach, liver, pancreas, endometrium, ovary and kidneys. But a reduced risk was seen for prostate and breast cancers, researchers reported. In type 1 diabetes, the body cannot produce the hormone insulin, which helps regulate blood sugar levels. People with type 1 diabetes must be treated with insulin to survive. The good news from this study, said researcher Sarah Wild, is that it doesn't seem that insulin treatment is responsible for an increased risk of some cancers, which has been a concern. "This pattern of cancer risk [seen in the study] is similar to that seen for people with type 2 diabetes and people who are overweight," said Wild, a professor of epidemiology at the University of Edinburgh in the ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Diabetes, Type 1, Renal Cell Carcinoma, Ovarian Cancer, Pancreatic Cancer, Diabetes Mellitus, Stomach Cancer, Wilms' Tumor

Researchers Pursue Clue Between Obesity, Breast and Pancreatic Cancer

Posted 20 Feb 2016 by Drugs.com

FRIDAY, Feb. 19, 2016 – Researchers believe they've unlocked at least one way that obesity may promote the progression of pancreatic and breast cancers. The finding could eventually lead to preventive treatments for those cancers, and maybe other cancers as well, the researchers said. "The fact that this new mechanism underlies obesity's impact on two types of cancer suggests that it may be a common mechanism of tumor induction that could apply to other cancer types," said study co-senior author Rakesh Jain. Director of the Laboratory of Tumor Biology at Massachusetts General Hospital in Boston, Jain made his comments in a hospital news release. More than half of people diagnosed with breast and pancreatic cancers are overweight or obese, the researchers said. Previous studies have linked obesity with an increased risk of death from these and other types of cancer, they added. However, ... Read more

Related support groups: Obesity, Breast Cancer, Pancreatic Cancer, Diagnosis and Investigation

Majority of Americans and Canadians Expects Cancer Cure in Their Lifetime

Posted 4 Feb 2016 by Drugs.com

THURSDAY, Feb. 4, 2016 – A majority of American and Canadian adults believe a cure for cancer will be found in their lifetime, and that a cancer diagnosis is not a death sentence, according to a new Harris Poll. Nearly three out of five Americans and Canadians expect a cure for cancer in their lifetime. That belief is especially strong among those ages 18 to 34. Nearly three-quarters of young Americans and 69 percent of Canadians in that age group expect a cure in their lifetime. And, about two-thirds of Americans and Canadians don't think death is inevitable when someone is diagnosed with cancer, the poll found. However, Americans adults under 35 are more likely to believe that a cancer diagnosis is a death sentence than those 35 and older (39 percent vs. 29 percent). Americans whose lives have been affected by cancer are also more likely to view cancer as deadly compared to those who ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Melanoma, Skin Cancer, Pancreatic Cancer, Ovarian Cancer, Cervical Cancer, Stomach Cancer, Head and Neck Cancer, Breast Cancer, Prevention, Breast Cancer - Palliative, Gastric Cancer, Testicular Cancer, Solid Tumors, Urinary Tract Cancer

Onivyde Approved for Advanced Pancreatic Cancer

Posted 27 Oct 2015 by Drugs.com

FRIDAY, Oct. 23, 2015 – The injected drug Onivyde (irinotecan liposome) has been approved by the U.S. Food and Drug Administration for pancreatic cancer that has either spread or is surgically untreatable. Pancreatic cancer is difficult to treat, the agency said, citing U.S. Government estimates that 48,960 new cases would be diagnosed this year and 40,560 would die from it. The new drug's effectiveness was evaluated in clinical studies involving 417 people with advanced pancreatic cancer. People treated with a combination of Onivyde and the anti-cancer drugs fluorouracil or leucovorin lived an average of 6.1 months, compared to 4.2 months among those treated with fluorouracil or leucovorin alone, the FDA said. Onivyde's most common side effects include diarrhea, fatigue, vomiting, loss of appetite, mouth inflammation and fever. The drug's label also warns that it may cause severe ... Read more

Related support groups: Pancreatic Cancer, Onivyde, Irinotecan Liposomal

FDA Approves New Pancreatic Cancer Drug Onivyde

Posted 27 Oct 2015 by Drugs.com

THURSDAY, Oct. 22, 2015 – The U.S. Food and Drug Administration has approved a new drug called Onivyde as part of a treatment regimen for advanced pancreatic cancer. Onivyde (irinotecan liposome injection) was approved to be used in combination with fluorouracil and leucovorin. The combination was approved for use in patients with advanced pancreatic cancer who were already treated with gemcitabine-based chemotherapy, the FDA said Thursday in a news release. The approval was based on a study of more than 400 patients. All had experienced cancer growth despite gemcitabine-based chemotherapy. The new research included three treatment arms. Patients were randomly assigned to receive Onivyde with fluorouracil/leucovorin, Onivyde alone, or fluorouracil/leucovorin alone. The researchers found that people treated with Onivyde plus fluorouracil/leucovorin lived an average of 6.1 months, ... Read more

Related support groups: Pancreatic Cancer, Onivyde, Irinotecan Liposomal

Page 1 2 3 4 5 6 7 Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

methotrexate, fluorouracil, Tarceva, Sutent, Afinitor, Gemzar, sunitinib, capecitabine, mitomycin, view more... gemcitabine, pancreatin, erlotinib, Abraxane, bevacizumab, everolimus, Hi-Vegi-Lip, cetuximab, Pan-2400, Pancreatin 4X, Adrucil, Digipepsin, Onivyde, irinotecan liposomal, paclitaxel protein-bound, streptozocin, Mutamycin, Zanosar, Donnazyme